Literature DB >> 33430492

Evidence of Pulmonary Hypertension after SARS-CoV-2 Infection in Subjects without Previous Significant Cardiovascular Pathology.

Cristina Tudoran1, Mariana Tudoran1, Voichita Elena Lazureanu2, Adelina Raluca Marinescu2, Gheorghe Nicusor Pop3, Alexandru Silvius Pescariu3, Alexandra Enache4, Talida Georgiana Cut3.   

Abstract

BACKGROUND: Coronavirus (Covid-19) infection represents a serious medical condition, often associated with cardiovascular complications, pulmonary hypertension (PH), and right ventricle dysfunction (RVD). The aim of this study is to show, by means of transthoracic echocardiography (TTE), the presence of an increased estimated systolic pressure in the pulmonary artery (esPAP) and altered right ventricular global longitudinal strain (RV-GLS) in patients without history of PH.
METHODS: In a group of 91 patients, aged under 55 years, hospitalized for a moderate Covid-19 infection, a thorough cardiologic and TTE examination were performed two months after discharge. Their initial thorax computer-tomography (TCT) images and laboratory data were accessed from the electronic data base of the hospital.
RESULTS: We observed an increased prevalence of PH (7.69%) and RVD (10.28%), significantly correlated with the initial levels of the TCT score and inflammatory factors (p ˂ 0.001), but borderline changes were observed in more patients. Multivariate regression analysis showed that these factors and RV-GLS explain 89.5% of elevated esPAP.
CONCLUSIONS: In COVID-19 infection, PH and RVD are common complications, being encountered after the recovery even in moderate cases. It appears to be a connection between their severity and the extent of the initial pulmonary injury and of the inflammatory response.

Entities:  

Keywords:  COVID-19; estimates systolic pulmonary pressure; pulmonary hypertension; right ventricle global longitudinal strain; thorax CT COVID score

Year:  2021        PMID: 33430492     DOI: 10.3390/jcm10020199

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  8 in total

Review 1.  Interaction between Sars-CoV-2 structural proteins and host cellular receptors: From basic mechanisms to clinical perspectives.

Authors:  Henry Wade; Qihua Duan; Qiaozhu Su
Journal:  Adv Protein Chem Struct Biol       Date:  2022-06-09       Impact factor: 5.447

2.  Heart rate variability comparison between young males after 4-6 weeks from the end of SARS-CoV-2 infection and controls.

Authors:  Mateusz Soliński; Agnieszka Pawlak; Monika Petelczyc; Teodor Buchner; Joanna Aftyka; Robert Gil; Zbigniew J Król; Jan J Żebrowski
Journal:  Sci Rep       Date:  2022-05-25       Impact factor: 4.996

3.  Evaluating Signs of Pulmonary Hypertension on Computed Tomography and Correlating With Echocardiography: A Study at a Tertiary Care Hospital.

Authors:  Abdur Rehman; Jaideep Darira; Muhammad Saad Ahmed; Kamran Hamid; Muhammad Kashif Shazlee; Syed Muhammad Shahnawaz Hyder
Journal:  Cureus       Date:  2022-05-25

Review 4.  Recent Advances and Future Prospects of Treatment of Pulmonary Hypertension.

Authors:  Adrija Hajra; Israel Safiriyu; Prasanth Balasubramanian; Rahul Gupta; Selia Chowdhury; Abhishek J Prasad; Akshay Kumar; Deepak Kumar; Baseer Khan; Roberta S F Bilberry; Ankit Sarkar; Paras Malik; Wilbert S Aronow
Journal:  Curr Probl Cardiol       Date:  2022-04-29       Impact factor: 16.464

Review 5.  Long-Term Lung Abnormalities Associated with COVID-19 Pneumonia.

Authors:  Jeffrey P Kanne; Brent P Little; Jefree J Schulte; Adina Haramati; Linda B Haramati
Journal:  Radiology       Date:  2022-08-30       Impact factor: 29.146

Review 6.  Endothelial metabolism in pulmonary vascular homeostasis and acute respiratory distress syndrome.

Authors:  Reece P Stevens; Sunita S Paudel; Santina C Johnson; Troy Stevens; Ji Young Lee
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-06-23       Impact factor: 6.011

Review 7.  "The possible implication of endothelin in the pathology of COVID-19-induced pulmonary hypertension".

Authors:  Omnia Azmy Nabeh; Lamiaa Mohammed Matter; Mahmoud Ahmed Khattab
Journal:  Pulm Pharmacol Ther       Date:  2021-10-01       Impact factor: 3.410

Review 8.  Echocardiographic assessment of the right ventricle in COVID-19: a systematic review.

Authors:  Simone Ghidini; Alessio Gasperetti; Luigi Biasco; Gregorio Tersalvi; Dario Winterton; Marco Vicenzi; Mattia Busana; Giovanni Pedrazzini
Journal:  Int J Cardiovasc Imaging       Date:  2021-07-22       Impact factor: 2.357

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.